Sanguisorba officinalis

Sanguisorba officinalis is a medicinal herb rich in bioactive tannins, flavonoids, and triterpenoid saponins — particularly ziyuglycoside I and II — that exert anti-inflammatory effects primarily by suppressing NF-κB signaling and pro-inflammatory cytokine production. Its extracts have demonstrated potential in managing intestinal inflammation and improving physical endurance in preclinical models.

Origin & History

Sanguisorba officinalis L., also known as Great Burnet, is a perennial herbaceous plant native to East Asia, traditionally used in Chinese and Japanese medicine. The medicinal preparation is derived from the roots and rhizomes, typically extracted using water or ethanol to produce liquid or powdered extracts containing polysaccharides, polyphenols, and tannins.

Historical & Cultural Context

Sanguisorba officinalis has been used for centuries in Chinese and Japanese traditional medicine for treating inflammatory conditions, hemostasis, diarrhea, dermatitis, nephritis, and colitis. The plant's hemostatic properties have been particularly emphasized in traditional practice and are now being investigated through modern research methods.

Health Benefits

• May reduce inflammation in ulcerative colitis by inhibiting inflammatory markers (IL-6, IL-1β, TNF-α) - based on mouse studies (PMID: 40518692)
• Potentially improves physical endurance by approximately 40% - shown in 4-week mouse study (PMID: PMC7998416)
• Supports autophagy in intestinal macrophages, shifting them toward anti-inflammatory profiles - demonstrated in mouse models (PMID: 32561763)
• Exhibits antioxidant activity through hydroxyl radical and DPPH scavenging - shown in in vitro studies
• Traditional hemostatic properties for bleeding disorders - historically documented but lacking modern clinical validation

How It Works

Sanguisorba officinalis suppresses the NF-κB signaling pathway, reducing transcription of pro-inflammatory cytokines including IL-6, IL-1β, and TNF-α relevant to conditions like ulcerative colitis. Its triterpenoid saponins and polyphenolic tannins also modulate autophagy in intestinal macrophages, potentially restoring mucosal homeostasis. Additionally, bioactive constituents may enhance mitochondrial biogenesis and oxidative capacity in skeletal muscle, contributing to the observed improvements in physical endurance.

Scientific Research

The current evidence for Sanguisorba officinalis consists primarily of animal studies and in vitro research, with no published human clinical trials, RCTs, or meta-analyses identified. Key studies include mouse models showing efficacy in DSS-induced colitis (PMID: 40518692, 32561763) and endurance improvement (PMID: PMC7998416), but human clinical validation is lacking.

Clinical Summary

Current evidence for Sanguisorba officinalis is largely preclinical. A mouse model of ulcerative colitis (PMID: 40518692) demonstrated significant reduction in IL-6, IL-1β, and TNF-α following extract administration, suggesting anti-inflammatory activity in the gut. A separate 4-week mouse study (PMC7998416) reported approximately 40% improvement in physical endurance measures. No large-scale randomized controlled trials in humans have been published to date, meaning efficacy and optimal dosing in humans remain unestablished.

Nutritional Profile

Sanguisorba officinalis (Great Burnet) contains a range of bioactive polyphenols as its primary functional constituents. Tannins are the dominant compound class, comprising approximately 17-20% dry weight, predominantly ellagitannins (sanguiin H-6, agrimoniin) and gallotannins (ziyuglycoside I and II). Triterpenoid saponins (ziyuglycoside series) are present at approximately 1-3% dry weight and are considered key pharmacologically active compounds. Flavonoids including quercetin, kaempferol, and their glycosides are present at roughly 0.5-1.5% dry weight. Catechins and condensed tannin precursors contribute additional antioxidant capacity. Phenolic acids including gallic acid and ellagic acid are detected at approximately 0.3-0.8% dry weight. The root, which is the primary medicinal part used in European and East Asian traditions, contains higher concentrations of these compounds than aerial parts. Mineral content includes iron, calcium, and potassium in modest quantities typical of root vegetables, though precise concentrations in dried root preparations are not well-documented in Western literature. Fiber content (primarily structural polysaccharides) represents approximately 20-30% of dry weight in root preparations. Protein content is low, estimated at 5-8% dry weight. Bioavailability note: ellagitannins are hydrolyzed in the gut to ellagic acid, which is further metabolized by intestinal microbiota to urolithins (urolithin A, B), which are considered the primary bioavailable anti-inflammatory metabolites; individual conversion capacity varies significantly based on gut microbiome composition.

Preparation & Dosage

Animal studies used oral doses of 50 mg/kg over 4 weeks without observed toxicity. In vitro studies employed polysaccharide concentrations of 62.5-250 μg/mL. No clinically validated human dosage ranges are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Sophora japonica, turmeric, boswellia, quercetin, probiotics

Safety & Interactions

Sanguisorba officinalis has a long history of use in traditional Chinese medicine and is generally considered low-risk at typical herbal doses, but formal human safety trials are limited. Its high tannin content may inhibit absorption of iron, certain minerals, and some orally administered medications if taken simultaneously. Due to a lack of reproductive safety data, use during pregnancy and breastfeeding is not recommended. Potential interactions with anticoagulant or anti-inflammatory drugs should be monitored given its demonstrated effects on cytokine pathways.